Quarterly earnings are arriving this week. Options activity is picking up across several high-profile names.
FICO is one of the starkest charts in the market right now. The stock is down 63% year-to-date. Its RSI stands at just 16.5, deeply oversold territory. Barclays slashed its price target by 45% this week. The short interest days-to-cover sits at 6.6. With analyst return potential at 110%, options traders face a sharp choice between a dead-cat bounce and continued selling. Put positioning looks heavy given the relentless price decline.
NVDA carries a more complex signal. A director offloaded shares recently, a bearish insider data point heading into earnings season. The ORTEX short score is a relatively low 29.9, so short sellers are not piling in. But with a $5.5 trillion market cap and Taiwan's August export orders hitting a record $103 billion (up from $60 billion a year earlier, per Taiwan's Ministry of Economic Affairs), demand signals from the semiconductor supply chain remain strong. Call positioning in NVDA has likely stayed resilient.
GME is waking up again. Its DTC ratio stands at 8.4. The ORTEX short score is 55. RSI is at 65.9, the highest of the four names here. Analysts see 43% downside. Yet the stock is up 18% this year. That divergence often draws speculative call buyers betting on another squeeze.
NKE reports this week. Down 44% year-to-date, with a 4.77% forward yield, it sits at an RSI of 37.8. Options traders leaning bearish will note the DTC of 4.6 days. Those looking for a relief rally may eye calls. The print is the catalyst.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
